Facial rejuvenation with botulinum neurotoxin: An anatomical and experiential perspective

Journal of Cosmetic and Laser Therapy

Volumn 9, Issue SUPPL. 1, 2007, Pages 23-31

  Fagien, Steven ^a,b   Raspaldo, Hervé ^b,c  

^a Aesthetic Eyelid Plastic Surgery

^b Facial Plastic Surgery Center ^*  (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Aesthetic assessment; Botulinum neurotoxin type A; Facial rejuvenation; Functional anatomy; Injection technique

Indexed keywords

BOTULINUM TOXIN A; COSMETIC;

AGING; ARTICLE; ESTHETICS; FACE; FACE MUSCLE; FACIAL EXPRESSION; FUNCTIONAL ANATOMY; HUMAN; INJECTION SITE; MEDICAL DECISION MAKING; NECK; PATIENT SATISFACTION; PRIORITY JOURNAL; REJUVENATION; WRINKLE;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; FACE; HUMANS; NECK; NEUROMUSCULAR AGENTS; REJUVENATION;

EID: 34548859850     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/17429590701523836     Document Type: Article

References (16)

1. Raspaldo H, Bettens R, Giordano P. Midface enhancement. In: Vuyk HD, Lohuis PJ, editors. Facial Plastic and Reconstructive Surgery (Hodder Arnold Publication). New York: Oxford University Press; 2006. p. 105-22.
2. Carruthers J, Fagien S, Matarasso SL, and the Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg. 2004;114 6 suppl:1S-22S.
3. Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N, on behalf of the Botox Facial Aesthetics Study Team. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg. 2005;31:257-62.
4. Raspaldo H, Toma A. Endoscopic face lift. 4th European Congress of Oto-Rhino-Laryngology, Head and Neck Surgery, Berlin, Germany, 13-18 May 2000. Bologna: Medimond S.R.L; 2000. p. 483-92.
5. The American Society for Aesthetic Plastic Surgery. Cosmetic Surgery National Data Bank. 2006 statistics. The American Society for Aesthetic Plastic Surgery, Inc. Available at: http://www.surgery.org/download/2006stats.pdf (accessed March 22, 2007).
6. Saban Y, Polselli R, Santini J, Raspaldo H. Atlas of Surgical Anatomy of the Face and Neck. Paris: Masson; 1994.
7. Belhaouari L, Gassia V. L'Art de la Toxine Botulique [in French]. Rueil-Malmaison. France: Editions Arnette (Wolters Kluwer France); 2006.
8. Loos BM, Maas CS. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin N Am. 2003;11:439-43.
9. Rohrich RJ, Janis JE, Fagien S, Stuzin JM. The cosmetic use of botulinum toxin. Plast Reconstr Surg. 2003;112 5 suppl:177S-187S; quiz 188S, 192S; discussion 189S-191S.
10. Sommer B, Sattler G. Botulinum Toxin in Aesthetic Medicine. Blackwell Science: Boston; 2001.
11. Cohen JL, Dayan SH. Botulinum toxin type A in the treatment of dermatochalasis: an open-label, randomized, dose-comparison study. J Drugs Dermatol. 2006;5:596-601.
12. Fagien S. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Plast Reconstr Surg. 2003;112 5 suppl:6S-18S; discussion 19S-20S.
13. Trindade de Almeida AR, Marques E, de Almeida J, Cunha T, Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg. 2007;33 special issue:S37-S43.
14. Raspaldo H. Video-assisted endoscopic face-lift: evolution [in French]. Rev Laryngol Otol Rhinol (Bord). 1997;118:57-64.
15. Carruthers J, Carruthers A. Botulinum toxin A in the mid and lower face and neck. Dermatol Clin. 2004;22:151-8.
16. Kane MAC. The functional anatomy of the lower face as it applies to rejuvenation via chemodenervation. Facial Plast Surg. 2005;21:55-64.